Connexins as precocious markers and molecular targets for chemical and pharmacological agents in carcinogenesis

G Pointis1, C Fiorini, J Gilleron

  • 1INSERM U 670, Faculté de Médecine, 27 avenue de Valombrose, 06107 Nice cedex 02, France. pointis@unice.fr

Current Medicinal Chemistry
|September 28, 2007
PubMed

Insights

Gap junctions, formed by connexins, regulate cell functions. Loss of gap junction communication is linked to cancer, suggesting connexins may act as tumor suppressors.

Area of Science:

  • Cell biology
  • Oncology
  • Molecular biology

Background:

  • Gap junctions, formed by connexins, are crucial for cell communication and homeostasis.
  • Dysfunctional gap junctions and connexin loss are hallmarks of cancer, often linked to carcinogen exposure.
  • Aberrant cytoplasmic localization of connexins is frequently observed in human neoplasia.

Purpose of the Study:

  • To review the role of connexins and gap junctions in carcinogenesis.
  • To explore the tumor suppressor functions of connexins.
  • To discuss connexins as potential targets for cancer chemoprevention and chemotherapy.

Main Methods:

  • Literature review of studies on gap junctions, connexins, and cancer.
  • Analysis of connexin involvement in cell homeostasis, proliferation, differentiation, and death.
  • Examination of connexin mechanisms in tumor suppression, including channel formation and direct effects.

Main Results:

  • Connexin dysfunction and loss of gap junction communication are associated with various human cancers.
  • Restoring connexin expression can reverse the transformed phenotype, supporting their tumor suppressor role.
  • Connexin-mediated tumor suppression mechanisms are diverse and cell/connexin type-dependent.

Conclusions:

  • Connexins play a significant role in cancer development and progression.
  • Connexins exhibit tumor suppressor activities through multiple mechanisms.
  • Targeting connexins offers potential for novel cancer chemoprevention and chemotherapy strategies.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...